Canales de SAEI.ORG
Eur J Clin Microbiol Infect Dis
Titulares
Resúmenes
Abstract Commercial nucleic acid amplification tests (NAATs) have become one of the most frequently used tests for detecting
Chalmydia trachomatis. However, published studies have raised important concerns regarding the NAAT evaluation process in general and their reproducibility
and clinical specificity in particular. This is because for many infectious diseases including chlamydia, a true gold standard
simply does not exist and, as a result, estimation of test performance parameters in the absence of a gold standard is a difficult
and challenging task. In this manuscript, we will attempt to address some issues pertaining to the evaluation of NAATs including
NAAT reproducibility, test validity, and the manner in which positive NAAT results are confirmed. Finally, we will discuss
some of the potential clinical and public health implications of testing by NAATs.
Content Type: Journal ArticleCategory ReviewDOI 10.1007/s10096-008-0586-3
Authors
A. Hadgu, Centers for Disease Control and Prevention Division of STD Prevention Atlanta GA USAM. Sternberg, Centers for Disease Control and Prevention Division of STD Prevention Atlanta GA USA
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Detection of
Pseudomonas aeruginosa
producing metallo-ß-lactamase VIM-2 in a central hospital from Portugal
Content Type: Journal ArticleCategory Brief ReportDOI 10.1007/s10096-008-0579-2
Authors
A. Pena, University of Coimbra Laboratory of Microbiology, Centro de Estudos Farmacêuticos, Faculty of Pharmacy Couraça dos Apostolos 51 r/c esq 3000-432 Coimbra PortugalA. M. Donato, University of Coimbra Laboratory of Clinical Analysis of the Faculty of Pharmacy Couraça dos Apostolos 51 r/c esq 3000-432 Coimbra PortugalA. F. Alves, Laboratory of Microbiology, Centro Hospitalar de Coimbra Quinta dos Vales, S. Martinho do Bispo 3046-853 Coimbra PortugalR. Leitão, University of Coimbra Laboratory of Microbiology, Centro de Estudos Farmacêuticos, Faculty of Pharmacy Couraça dos Apostolos 51 r/c esq 3000-432 Coimbra PortugalO. M. Cardoso, University of Coimbra Laboratory of Microbiology, Centro de Estudos Farmacêuticos, Faculty of Pharmacy Couraça dos Apostolos 51 r/c esq 3000-432 Coimbra Portugal
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract The purpose of this study was to assess the one-year efficacy of highly active antiretroviral therapy (HAART) administered
by general practitioners in a primary care community clinic in rural South Africa. We performed an observational cohort study
of 675 treatment-naïve human immunodeficiency virus (HIV)-infected patients (including 66 children) who began HAART at least
12 months prior to the data analyses. Throughout treatment, the CD4+ T-cell count (percentage of CD4+ T-cells in children)
and plasma HIV-RNA level were determined and the patient's weight was recorded. The primary outcome was mortality. Secondary
outcomes were viral suppression, immunological response, and weight gain. One year after the start of HAART, 100 of the 675
(15%) patients were lost to follow-up and 119 patients (18%), including six children, died. Mortality was highest during the
first few months of treatment. Based on an on-treatment analysis at one year after the start of therapy, 83% of adults and
71% of children had a viral load <400 copies/ml; the viral load was <50 copies/ml in 70% of adults and 61% of children. At
one year, the mean CD4+ T-cell count in adults had increased by 236/mm
3, and the mean body mass index (BMI) had increased by 3.5 kg/m
2. In children, the mean CD4% had increased by 17.6. A low Karnofsky score and a low baseline CD4+ T-cell count were independently
associated with death. In addition to these factors, a low baseline BMI and gender were predictive of a poor immunological
outcome. Our study shows that adequately monitored HIV/acquired immunodeficiency syndrome (AIDS) care administered by general
practitioners and their staff is feasible and leads to good results in a rural, primary care center in sub-Saharan Africa.
In order to achieve even better results, early mortality should be reduced and efforts should be made to start HAART earlier.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0534-2
Authors
R. E. Barth, University Medical Centre Utrecht Department of Internal Medicine and Infectious Diseases and the Eijkman-Winkler Institute for Medical Microbiology and Infectious Diseases Heidelberglaan 100 3584 CX Utrecht The NetherlandsJ. T. M. van der Meer, Academic Medical Centre, University of Amsterdam Department of Internal Medicine, Subdivision of Infectious Diseases, Tropical Medicine and AIDS Meibergdreef 9 Postbus 22660 1100 DD Amsterdam The NetherlandsA. I. M. Hoepelman, University Medical Centre Utrecht Department of Internal Medicine and Infectious Diseases and the Eijkman-Winkler Institute for Medical Microbiology and Infectious Diseases Heidelberglaan 100 3584 CX Utrecht The NetherlandsP. A. Schrooders, Ndlovu Medical Centre Elandsdoorn Mpumalanga South AfricaD. A. van de Vijver, University Medical Centre Utrecht Department of Virology Heidelberglaan 100 3584 CX Utrecht The NetherlandsS. P. M. Geelen, University Medical Centre Utrecht and PharmAccess Foundation Department of Pediatric Infectious Diseases Amsterdam The NetherlandsH. A. Tempelman, Ndlovu Medical Centre Elandsdoorn Mpumalanga South Africa
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Data about predictors of embolism in patients with infective endocarditis (IE) are conflicting. This study aimed to investigate
clinical and transoesophageal echocardiography (TEE) characteristics in predicting embolism and six-month mortality. In this
observational cohort study, 216 patients with definite left-sided IE, according to the modified Duke criteria, were prospectively
recruited. All patients underwent TEE. 'Any embolism' was defined as embolism before or after initiation of antimicrobial
therapy; 'new embolism' included embolism after initiation of antimicrobial therapy. Sixty-two of 216 patients (29%) experienced
any embolism. New embolism occurred in 12 patients (6%), 7 of which were postoperative. Factors significantly associated with
any embolism were community origin of IE and the etiologic microorganism, in particular staphylococci and nonviridans streptococci.
Vegetation length >10 mm showed a trend towards association with new embolism and a mobile vegetation was predictive for new
embolism. Six-month mortality was 24% (52/216). In multivariable analysis, age, vegetation length >10 mm,
Staphylococcus aureus, and the type of treatment predicted mortality. Multiple emboli showed a trend towards association with death. In conclusion,
any embolism occurred in over a fourth of patients. A mobile vegetation was significantly associated with new embolism, and
vegetation length >10 mm tended to be associated with new embolism. Vegetation length >10 mm predicted six-month mortality,
and multiple emboli showed a trend towards association with death.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0572-9
Authors
Evelyn E. Hill, University Hospital Gasthuisberg K.U. Leuven Department of Internal Medicine – Infectious Diseases 3000 Leuven BelgiumPaul Herijgers, University Hospital Gasthuisberg K.U. Leuven Department of Cardiac Surgery 3000 Leuven BelgiumPiet Claus, University Hospital Gasthuisberg K.U. Leuven Department Cardiology Herestraat 49 3000 Leuven BelgiumSteven Vanderschueren, University Hospital Gasthuisberg K.U. Leuven Department of Internal Medicine – Infectious Diseases 3000 Leuven BelgiumWilly E. Peetermans, University Hospital Gasthuisberg K.U. Leuven Department of Internal Medicine – Infectious Diseases 3000 Leuven BelgiumMarie-Christine Herregods, University Hospital Gasthuisberg K.U. Leuven Department Cardiology Herestraat 49 3000 Leuven Belgium
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Leprosy is still an endemic disease, especially in Third World countries, and, because of migration, it still persists in
Europe and the United States. The disease affects the peripheral nerves, skin, and multiple internal organs, making its clinical
recognition difficult. In particular, the endocrine manifestations caused by leprosy have been underestimated, even by specialists.
The endocrine changes present in leprosy include hypogonadism, sterility, and osteoporosis. In addition, the spectral immune
nature of leprosy offers an attractive model to investigate the pathogenetic correlation between the patterns of inflammation
in the poles of its spectrum and the hormonal disarrangements observed in this disease. It is important that those involved
in leprosy management be aware of the potential endocrine changes and their treatment to address the disease in all of its
aspects. In this article, we review the findings on endocrine dysfunction in leprosy, including a survey of the literature
and of our own work.
Content Type: Journal ArticleCategory ReviewDOI 10.1007/s10096-008-0576-5
Authors
Â. M. O. Leal, Federal University of São Carlos Department of Medicine São Carlos SP Brazil 13565-905N. T. Foss, University of São Paulo School of Medicine of Ribeirão Preto Ribeirão Preto SP Brazil
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Premature infants are vulnerable to severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) resulting
in hospitalisation and the potential for longer-term respiratory morbidity. Whilst the severity and consequence of RSV LRTI
are generally accepted and recognised in infants born =32 weeks gestational age (GA), there is less acknowledgment of the
potential consequences in infants born 33 – 35 weeks GA. However, there is a growing body of evidence suggesting that infants
born between 33 and 35 weeks GA may be equally at risk for RSV LRTI as infants born <32 weeks GA. Interrupted lung development
and an immature immune system have been linked with an increased susceptibility for RSV LRTI, along with other environmental,
social, and physiological risk factors. Currently, the only effective method of preventing RSV LRTI is prophylaxis with palivizumab.
Often with limited healthcare resources, identifying infants at greatest risk of RSV LRTI who would potentially benefit most
from prophylaxis is highly desirable, particularly in the 33 – 35-week GA group. The purpose of this article is to examine the
causes and consequences of RSV LRTI in infants born 33 – 35 weeks GA, and look at the potential for using risk factors to identify
high risk infants and, thereby, optimise prophylaxis. The causes and consequences of RSV LRTI in infants born 33 – 35 weeks
GAA were determined via literature review. A number of underlying risk factors that significantly increase the risk of severe
RSV LRTI and subsequent hospitalisation in this group of infants have been identified, most notably from the FLIP and PICNIC
studies. A European predictive model based on the risk factors in the FLIP study has recently been developed and validated,
which will aid identification of infants born between 33 and 35 weeks GA with the highest risk of RSV hospitalisation. Implementation
of this model and prophylaxis of infants born between 33 and 35 weeks GA should be a national or regional decision, taken
in perspective of other public health needs.
Content Type: Journal ArticleCategory ReviewDOI 10.1007/s10096-008-0520-8
Authors
X. Carbonell-Estrany, Institut Clínic de Ginecologia Obstetricia i Neonatologia, Neonatology Service Hospital Clínic Barcelona SpainL. Bont, University Medical Center Wilhelmina Children's Hospital Utrecht The NetherlandsG. Doering, Munich GermanyJ-B. Gouyon, Hôpital d'Enfants Service de Pédiatrie 2 Dijon Cedex FranceM. Lanari, Hospital of Imola Pediatrics and Neonatology Unit Imola Italy
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract A retrospective study investigating all the infectious encephalitis cases hospitalized at the pediatric intensive care unit
of Edouard Herriot University Hospital in Lyon, France, was carried out in order to estimate the prevalence of
Mycoplasma pneumoniae in acute childhood encephalitis. From January 2001 to December 2005, the cases of 29 children were selected and reviewed.
M. pneumoniae related encephalitis was considered as probable in five cases (17%) on the basis of positive serological tests or positive
polymerase chain reaction (PCR) tests in throat or nasopharyngeal swab while the PCR tests performed from the cerebrospinal
fluid were negative. This study suggests that
M. pneumoniae may be a major cause of infectious encephalitis in children as well as enteroviruses or Epstein-Barr virus detected in five
and three cases, respectively.
Content Type: Journal ArticleCategory Concise ArticleDOI 10.1007/s10096-008-0591-6
Authors
C. Domenech, Université Claude Bernard Lyon 1 Hôpital Edouard Herriot, Hospices Civils de Lyon Lyon FranceN. Leveque, Université Claude Bernard Lyon 1 Laboratoire de Virologie est, Hospices Civils de Lyon Lyon FranceB. Lina, Université Claude Bernard Lyon 1 Laboratoire de Virologie est, Hospices Civils de Lyon Lyon FranceF. Najioullah, Université Claude Bernard Lyon 1 Laboratoire de Virologie est, Hospices Civils de Lyon Lyon FranceD. Floret, Université Claude Bernard Lyon 1 Hôpital Edouard Herriot, Hospices Civils de Lyon Lyon France
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Medical records and incidence data were analyzed retrospectively to document the epidemiology, clinical features, and outcomes
of mumps in relation to vaccination status in the Lviv province of Ukraine over a 7.5-year period, beginning in 2000, when
a second dose of mumps vaccine was introduced. Lviv, 1 of 27 provinces in western Ukraine, with a land area of 21,833 km
2, had a total population of about 2,555,834 in 2006. The initial success of the second dose introduction in 2000 in Ukraine
was limited by a local outbreak of mumps in Lviv province in 2000 – 2002 due to a vaccine shortage; most cases were over the
age of 7 years. The vaccine with the Leningrad-3 virus strain used before 2001 was then replaced by the triple vaccine 'Priorix',
with the RIT 4385 derivate of the Jeryl Lynn strain, Belgium. Orchitis and aseptic meningitis were associated with the Russian
vaccine. Of the 10,894 reported cases, the most severe (367 cases, 3.4%) were hospitalized in the Lviv Hospital for Infectious
Diseases. Admitted patients were predominantly male and over 14 years old. Of the 367 patients admitted to the Lviv Hospital
for Infectious Diseases, 45.8% had been vaccinated (mostly by a first dose of Russian vaccine), 15.9% had not been vaccinated,
and 38.1% had an unknown vaccination status. More mumps cases occurred in winter and spring than in summer and autumn. The
clinical picture and complications (orchitis, pancreatitis, meningitis, and encephalitis) were typical of this disease. The
vaccine shortage and an increase in the susceptible population among those who received the Russian vaccine contributed to
the outbreak. The use of vaccine with a derivate of the Jeryl Lynn strain has resulted in a dramatic drop in mumps cases since
2002.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0575-6
Authors
Y. Hrynash, Lviv National Medical University Department of Pediatric Infectious Diseases 69 Pekarska St. 79010 Lviv UkraineA. Nadraga, Lviv National Medical University Department of Pediatric Infectious Diseases 69 Pekarska St. 79010 Lviv UkraineM. Dasho, Lviv National Medical University Department of Pediatric Infectious Diseases 69 Pekarska St. 79010 Lviv Ukraine
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract The genotype of a Beijing strain of
Mycobacterium tuberculosis (MTB) is usually determined by spoligotyping. However, this technique requires special equipment and is time-consuming. In
this study, we developed a new multiplex polymerase chain reaction (PCR) to differentiate between Beijing and non-Beijing
strains of MTB. A total of 323 MTB isolates were genotyped by both spoligotyping and the novel multiplex PCR. By spoligotyping,
169 (52.3%) isolates were determined to be Beijing strains and the remaining 154 (47.7%) isolates were non-Beijing strains.
The multiplex PCR method produced results identical to those of spoligotyping in the identification of Beijing strains of
MTB. This method is highly sensitive, specific, and fast. It is also cost-effective and suitable for screening large numbers
of samples.
Content Type: Journal ArticleCategory Brief ReportDOI 10.1007/s10096-008-0590-7
Authors
J.-R. Sun, Tri-Service General Hospital Division of Clinical Pathology, Department of Pathology 325, Section 2, Cheng-Kung Road, Neihu 114 Taipei Taiwan ROCS.-Y. Lee, Tri-Service General Hospital Division of Clinical Pathology, Department of Pathology 325, Section 2, Cheng-Kung Road, Neihu 114 Taipei Taiwan ROCH.-Y. Dou, National Health Research Institutes Division of Clinical Research Zhunan Taiwan ROCJ.-J. Lu, Tri-Service General Hospital Division of Clinical Pathology, Department of Pathology 325, Section 2, Cheng-Kung Road, Neihu 114 Taipei Taiwan ROC
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Clinicians sometimes experience treatment failure in the initial empirical antibiotics treatment using cephalosporins in cirrhotic
patients with spontaneous bacterial peritonitis (SBP). Enterococcus, which is intrinsically resistant to cephalosporins, may
be one of the causes of treatment failure. The aim of this study was to evaluate the clinical importance and the clinical
characteristics of spontaneous enterococcal peritonitis (SEP). This was a retrospective cohort study of 359 patients with
SBP treated in a single tertiary care center in South Korea from January 2000 through December 2004. We evaluated the clinical
manifestation and the treatment results of SBP patients with enterococci identified from ascites culture. During the observation
period, 13 of 359 patients (3.6%) diagnosed with culture-positive SBP had enterococcal peritonitis. For the initial empirical
treatment, third-generation cephalosporins were administered to the 13 patients, ten of whom (76.9%) did not improve in the
first 48 h. An in vitro antibiotic sensitivity test showed that the identified enterococci were susceptible to ampicillin
plus gentamycin in eight patients (61.5%) and there was no vancomycin-resistant enterococcus. Although antibiotics were changed
to antienterococcal antibiotics in 11 patients, only five patients improved. As a result, eight of the 13 patients (61.5%)
with enterococcal SBP died during the observation period, and the one-month mortality was significantly higher from enterococcal
SBP than from nonenterococcal SBP (
P?=?0.038). We conclude that enterococcal SBP has poor prognosis and it is reasonable to use antienterococcal antibiotics when
enterococcus is identified from ascites culture of patients with liver cirrhosis.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0578-3
Authors
J.-H. Lee, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaJ.-H. Yoon, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaB. H. Kim, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaG. E. Chung, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaS. J. Myung, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaW. Kim, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaY. J. Kim, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of KoreaE.-C. Kim, Seoul National University College of Medicine Department of Laboratory Medicine Seoul Republic of KoreaH.-S. Lee, Seoul National University College of Medicine Department of Internal Medicine and Liver Research Institute 28 Yungun-dong, Chongno-gu Seoul 110 – 744 Republic of Korea
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Microbiologic studies are routinely performed in the assessment of peritonsillar abscess (PTA). Though the bacterial growth
rates of PTA are expected to be uniform due to high accessibility and reasonable sterility, they demonstrate a vast range
of results, which is partially explained by the differing culturing methods and incubation times. Our aim was to retrospectively
examine the changing features identified in the occurrence of PTA bacterial growth rates over a period of seven years. A retrospective
study was undertaken on all cases of PTA admitted from January 1996 to December 2002. Details regarding sex, age and country
of birth were obtained. Population data and the maximum residue level (MRL) of antibiotics in food were collected. Bacteriologic
studies were analysed for gram stain, aerobic and anaerobic culture results, and also antibiotic sensitivities, if obtained.
Four hundred and fifty-seven consecutive hospitalisations due to PTA were identified; 281 patients who had 310 hospitalisations
with known results of the microbiologic studies were included. The most common pathogens were
Streptococcus pyogenes and
Prevotella. A statistically significant escalation was seen in the anaerobic growth rate from 6.8% of cases in 1996 to 37% in 1999.
A similar change, though not significant, was noticed with the polymicrobial growth rate. None of the parameters investigated
showed any statistically significant influence on this tendency. These results may clarify the immense range of bacterial
study results reported, suggest a change in the biologic behaviour of the studied bacteria and direct further research.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0583-6
Authors
H. Gavriel, Assaf Harofeh Medical Center Department of Otolaryngology Head and Neck Surgery Zerifin 70300 IsraelT. Lazarovitch, Assaf Harofeh Medical Center Department of Microbiology Zerifin 70300 IsraelA. Pomortsev, Assaf Harofeh Medical Center Department of Otolaryngology Head and Neck Surgery Zerifin 70300 IsraelE. Eviatar, Assaf Harofeh Medical Center Department of Otolaryngology Head and Neck Surgery Zerifin 70300 Israel
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract We describe the control of a hospital-wide vancomycin-resistant
Enterococcus faecium (VRE) outbreak in a 2,000-bed university hospital located on three different sites in Clermont-Ferrand, France. From January
2004 to April 2007, 220 VRE cases were identified. Overall, 28 different wards had at least one case. All of the strains expressed
a high level of resistance to vancomycin and to teicoplanin carried by the
vanA gene. Pulsed-field gel electrophoresis (PFGE) analysis of the strains revealed that they were clonally related. Control
measures consisted of implementing a strategy of VRE screening by rectal swab, reinforcing hand hygiene practices and taking
contact precautions. Recommendations for a restricted use of specific antibiotics were sent to each physician. Alcohol-based
handrubs were provided throughout the hospital and the staff underwent training for their use. Compliance with contact precautions,
including the use of clean non-sterile gloves and single-use gowns, was reinforced. VRE cases were assigned systematically
to a single-bed room. In October 2007, no new VRE carriage has been detected for 7 months and no clinical samples had been
VRE-positive for 10 months. In conclusion, a hospital-wide VRE outbreak was successfully controlled by a strategy based on
routine screening, the reinforcement of hand hygiene and taking barrier precautions.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0544-0
Authors
C. Aumeran, Centre Hospitalier Universitaire de Clermont-Ferrand Université Clermont1 Clermont-Ferrand FranceO. Baud, Centre Hospitalier Universitaire de Clermont-Ferrand Université Clermont1 Clermont-Ferrand FranceO. Lesens, Centre Hospitalier Universitaire de Clermont-Ferrand Service des Maladies Infectieuses et Tropicales Clermont-Ferrand FranceJ. Delmas, Centre Hospitalier Universitaire de Clermont-Ferrand Laboratoire de Bactériologie Clermont-Ferrand FranceB. Souweine, Centre Hospitalier Universitaire de Clermont-Ferrand CLIN Clermont-Ferrand FranceO. Traoré, Centre Hospitalier Universitaire de Clermont-Ferrand Université Clermont1 Clermont-Ferrand France
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Mannose-binding lectin (MBL) plays an important role in innate immunity mediating phagocytosis and activating the MBL complement
pathway. Few studies, conducted in adult populations, have shown that genetically determined low MBL levels may confer partial
protection against tuberculosis (TB). In this study we aimed to investigate the relationships between the susceptibility to
TB and two low producing MBL2 gene polymorphisms (codons 54 and 57) and MBL levels in children. Forty-four TB children (27
pulmonary TB, 17 extrapulmonary TB) and 99 age-matched healthy control children were included in the study. The mean age in
the study group was 7.02?±?4.5 years. Genotyping of the MBL2 gene for codon 54 and 57 polymorphisms was carried out, and MBL
levels in serum were also detected in all subjects from both groups. None of the subjects from either group showed codon 57
polymorphisms. The frequency of the AB genotype which produces low level MBL is significantly lower in the patients (9.1%)
compared to control subjects (27.3%) (
p?<?0.011). The difference was especially significant between the extrapulmonary group and healthy controls (
p?<?0.006). The BB genotype was observed in only one child from the healthy controls and no children from the patient group.
The median MBL plasma concentration was also significantly lower in the control group than that found in the study group (
p?=?0.036). These results indicate that low levels of MBL and AB genotype may be involved in the protection against tuberculosis,
especially extrapulmonary tuberculosis in children.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0573-8
Authors
H. Cosar, Ege University Department of Pediatrics, Faculty of Medicine Izmir TurkeyF. Ozkinay, Ege University Department of Pediatrics, Faculty of Medicine Izmir TurkeyH. Onay, Ege University Department of Medical Genetics, Faculty of Medicine Izmir TurkeyN. Bayram, Ege University Department of Pediatrics, Faculty of Medicine Izmir TurkeyA. R. Bakiler, Adnan Menderes University Department of Pediatrics, Faculty of Medicine Aydin TurkeyM. Anil, Tepecik Social Workers Hospital Izmir TurkeyD. Can, Dr Behcet Uz Children Hospital Izmir TurkeyC. Özkinay, Ege University Department of Medical Genetics, Faculty of Medicine Izmir Turkey
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract
Objectives The correlation of immune activation with CD4
+ depletion and HIV-1 disease progression has been evidenced by several studies involving mainly clade B virus. However, this
needs to be investigated in developing countries such as India predominately infected with clade C virus.
Materials and methods In a cross-sectional study of 68 antiretroviral treatment naïve, HIV-1 infected Indian patients, we studied the association
between CD4
+ T cells, plasma HIV-1 RNA levels, and immune activation markers using unadjusted and adjusted correlative analyses.
Results Significant negative correlations of higher magnitude were observed between the CD4
+ T cell percentages and plasma HIV-1 RNA levels in the study population when adjusted for the effects of immune activation
markers. However, the negative association of CD4
+ T cells with immune activation markers remained unaffected when controlled for the effects of plasma HIV-1 RNA levels.
Conclusions Our results support the important role of immune activation in CD4
+ T cell depletion and disease progression during untreated HIV-1 infection.
Content Type: Journal ArticleCategory Concise ArticleDOI 10.1007/s10096-008-0582-7
Authors
M. Vajpayee, All India Institute of Medical Sciences (A.I.I.M.S.) HIV & Immunology Division, Department of Microbiology Ansari Nagar New Delhi 110029 IndiaS. Kaushik, All India Institute of Medical Sciences (A.I.I.M.S.) HIV & Immunology Division, Department of Microbiology Ansari Nagar New Delhi 110029 IndiaV. Sreenivas, All India Institute of Medical Sciences (A.I.I.M.S.) Department of Biostatistics New Delhi IndiaK. Mojumdar, All India Institute of Medical Sciences (A.I.I.M.S.) HIV & Immunology Division, Department of Microbiology Ansari Nagar New Delhi 110029 IndiaS. Mendiratta, All India Institute of Medical Sciences (A.I.I.M.S.) HIV & Immunology Division, Department of Microbiology Ansari Nagar New Delhi 110029 IndiaN. K. Chauhan, All India Institute of Medical Sciences (A.I.I.M.S.) HIV & Immunology Division, Department of Microbiology Ansari Nagar New Delhi 110029 India
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract The goal of this study was to develop a liquid culture medium for the rapid isolation, cultivation, identification and subsequent
antibiotics susceptibility testing of
Helicobacter pylori directly from biopsy specimens. Five liquid media were tested: Ham's F-12, Brucella broth, tryptic soybroth, brain heart
infusion broth and Mueller-Hinton broth. After optimisation of the medium, it was applied in order to investigate biopsy samples
from 150 patients with gastro-duodenal disorders and compared with traditional culture methods, microscopy and an
H. pylori-specific TaqMan real-time polymerase chain reaction (PCR). The most reliable and rapid growth of
H. pylori, even at a small inoculum size, was obtained in Ham's F-12 medium with 5% horse serum. The developed system allowed the primary
isolation of
H. pylori in clinical samples and provided 87% sensitivity and 100% specificity.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0567-6
Authors
N. Sainsus, State University of Medicine and Pharmacy 'N. Testemitanu' Department of Microbiology 165, bd. Stefan cel Mare si Sfint 2004 Chishinau MoldovaV. Cattori, University of Zurich Clinical Laboratory, Vetsuisse Faculty Winterthurerstr. 260 8057 Zurich SwitzerlandC. Lepadatu, State University of Medicine and Pharmacy 'N. Testemitanu' Department of Surgery, Faculty of CME, Clinical Republican Hospital Testemitanu 29 2025 Chishinau MoldovaR. Hofmann-Lehmann, University of Zurich Clinical Laboratory, Vetsuisse Faculty Winterthurerstr. 260 8057 Zurich Switzerland
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract The purpose of this study was to evaluate the overall performance of rapid antigen detection (RAD) in group A streptococcus
(GAS) in Finland by using the results of external quality assurance (EQA) samples. We also compared the performance of laboratory
professionals to that of nursing professionals. Around 22,800 EQA results among a total of 383 laboratories and physician's
offices were analysed. Vocational data on the personnel who carried out the tests were available for 10,088 EQA samples, 7,428
of which were tested by laboratory technicians and 2,531 by nursing staff. The best overall performance was found with GAS-negative
samples: 99% of the reports were correct. In contrast, the overall performance was only 76% when the samples were weakly positive
for GAS antigen. The laboratory technicians performed statistically significantly better than the nursing staff, with both
strongly positive (correct results 98.9% vs. 95.1%, respectively;
p<0.001) and weakly positive (79.3% vs. 65.3%, respectively;
p<0.001) samples. With negative samples, no difference in performance between the laboratory and nursing staff was found (99.5%
vs. 99.0%, respectively). The professional skills of the person performing the RAD test for GAS have a major impact on the
sensitivity of the test. Based on the results of this study, we suggest that EQA-like artificial specimens could be used as
a tool to improve and validate the quality of RAD testing in individual testing sites.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0580-9
Authors
A. Nissinen, Central Hospital of Central Finland Microbiology Laboratory Keskussairaalantie 19 40620 Jyväskylä FinlandP. Strandén, National Public Health Institute (KTL) Enteric Bacteria Laboratory, Department of Bacterial and Inflammatory Diseases Helsinki FinlandR. Myllys, Labquality Oy Helsinki FinlandJ. Takkinen, National Public Health Institute (KTL) Department of Infectious Diseases Epidemiology Helsinki FinlandY. Björkman, Labquality Oy Helsinki FinlandP. Leinikki, National Public Health Institute (KTL) Department of Infectious Diseases Epidemiology Helsinki FinlandA. Siitonen, National Public Health Institute (KTL) Enteric Bacteria Laboratory, Department of Bacterial and Inflammatory Diseases Helsinki Finland
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract The treatment of cystic fibrosis (CF) patients chronically infected with
Burkholderia cepacia complex (Bcc) bacteria requires extensive and aggressive antibiotics therapy, exposing these bacteria to prolonged antibiotics-selective
pressure. In the present study, we have compared the susceptibility patterns to 13 antimicrobials of 94 Bcc isolates obtained
from 15 Portuguese CF patients in the course of chronic infection during a five-year survey. These isolates were previously
genotyped and represent 11 different strains of the species
B. cenocepacia (subgroups A and B),
B. cepacia,
B. multivorans, and
B. stabilis. The results are consistent with the notion that CF Bcc isolates are resistant to the most clinically relevant antimicrobials
and suggest an uneven distribution of resistance rates among the different species, with
B. cenocepacia subgroup A isolates being the most resistant. Phenotypic variants exhibiting differences in the antimicrobial susceptibility
patterns were obtained from the sputum samples of clinically deteriorated CF patients during chronic lung infection. The isolation
of resistant variants coincided with periods of pulmonary exacerbation and antibiotics therapy.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0552-0
Authors
J. H. Leitão, Instituto Superior Técnico IBB — Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering Av. Rovisco Pais 1049-001 Lisboa PortugalS. A. Sousa, Instituto Superior Técnico IBB — Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering Av. Rovisco Pais 1049-001 Lisboa PortugalM. V. Cunha, Instituto Superior Técnico IBB — Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering Av. Rovisco Pais 1049-001 Lisboa PortugalM. J. Salgado, Hospital de Santa Maria Laboratório de Bacteriologia Av. Prof. Egas Moniz Lisboa PortugalJ. Melo-Cristino, Hospital de Santa Maria Laboratório de Bacteriologia Av. Prof. Egas Moniz Lisboa PortugalM. C. Barreto, Hospital de Santa Maria Centro Especializado em Fibrose Quística Av. Prof. Egas Moniz Lisboa PortugalI. Sá-Correia, Instituto Superior Técnico IBB — Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering Av. Rovisco Pais 1049-001 Lisboa Portugal
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract The aim of this study was to characterize the molecular epidemiology of invasive and non-invasive group A streptococcus (GAS)
infections in children from 1997 through 2004 in southern Taiwan. A collection of 32 invasive and 150 non-invasive isolates
were recruited for analysis.
emm1 (34.4%) and
emm12 (40.0%) predominated in the invasive and non-invasive isolates, respectively. The peak incidence of invasive GAS infection
(IGASI) occurred between 2002 and 2003.
emm4 and
emm12 were the major types among clinical isolates before 2001, and was replaced by
emm1 during 2002 – 2003. All
emm1 isolates were clonal relatedness. The declined prevalence of erythromycin resistance occurred in the major shift of the
endemic isolates to
emm1 strains during 2002 – 2003 in the community.
Content Type: Journal ArticleCategory Brief ReportDOI 10.1007/s10096-008-0561-z
Authors
H.-C. Lin, Centers for Disease Control Taipei TaiwanS.-M. Wang, National Cheng Kung University Medical College and Hospital Department of Emergency Medicine Tainan TaiwanY.-L. Lin, National Cheng Kung University Medical College and Hospital Department of Pediatrics 138 Sheng Li Road Tainan 70428 TaiwanY.-S. Lin, National Cheng Kung University Medical College Department of Microbiology and Immunology Tainan TaiwanJ.-J. Wu, National Cheng Kung University Medical College Department of Medical Laboratory Science and Biotechnology Tainan TaiwanW.-J. Chuang, National Cheng Kung University Medical College Department of Biochemistry Tainan TaiwanM. T. Lin, National Cheng Kung University Medical College Department of Biochemistry Tainan TaiwanC.-C. Liu, National Cheng Kung University Medical College and Hospital Department of Pediatrics 138 Sheng Li Road Tainan 70428 Taiwan
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract Whipple's disease is a systemic chronic infection caused by
Tropheryma whipplei. Asymptomatic people may carry
T. whipplei in their digestive tract and this can be determined by PCR, making serological diagnosis useful to distinguish between carriers
and patients. Putative antigenic proteins were selected by computational analysis of the
T. whipplei genome, immunoproteomics studies and from literature. After expression, putative
T. whipplei antigens were screened by microimmunofluorescence with sera of immunized rabbit. Selected targets were screened by microarray
using sera from patients and carriers. Paradoxically, with 19 tested recombinant proteins and a glycosylated native protein
of
T. whipplei, a higher immune response was observed with asymptomatic carriers. In contrast, quantification of human IgA exhibited a higher
reaction in patients than in carriers against 10 antigens. These results were used to design a diagnostic test with a cut-off
value for each antigen. A blind test assay was performed and was able to diagnose 6/8 patients and 11/12 carriers. Among people
with positive
T. whipplei PCR of the stool, patients differ from carriers by having positive IgA detection and a negative IgG detection. If confirmed,
this serological test will distinguish between carriers and patients in people with positive PCR of the stool.
Content Type: Journal ArticleCategory ArticleDOI 10.1007/s10096-008-0528-0
Authors
C. J. Bonhomme, Université de la Méditerranée Unité des Rickettsies, CNRS UMR 6236, Faculté de Médecine 27 Boulevard Jean Moulin 13005 Marseille FranceP. Renesto, Université de la Méditerranée Unité des Rickettsies, CNRS UMR 6236, Faculté de Médecine 27 Boulevard Jean Moulin 13005 Marseille FranceS. Nandi, Jawaharlal Nehru University School of Information Technology New Delhi 110067 IndiaA. M. Lynn, Jawaharlal Nehru University School of Information Technology New Delhi 110067 IndiaD. Raoult, Université de la Méditerranée Unité des Rickettsies, CNRS UMR 6236, Faculté de Médecine 27 Boulevard Jean Moulin 13005 Marseille France
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723
Abstract In the pre-antibiotics era, syphilis was an extremely common disease. The first well-recorded European outbreak of what is
now known as syphilis occurred in 1494, when it appeared among French troops besieging Naples. Thereafter, the disease spread
all over Europe and, in the 18th and 19th centuries, many artists became victims of syphilis, among them poets, painters,
philosophers, and musicians and composers. This review presents biographies of several musicians and composers that probably
suffered from syphilis.
Content Type: Journal ArticleCategory ReviewDOI 10.1007/s10096-008-0571-x
Authors
C. Franzen, University of Regensburg Department for Internal Medicine I 93042 Regensburg Germany
European Journal of Clinical Microbiology & Infectious DiseasesOnline ISSN: 1435-4373Print ISSN: 0934-9723